ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 362 out of 2094

$510K Total Retail Price of All Prescriptions

Rank: 481 out of 2094

259 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 259 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 382 282 1 3
OMEPRAZOLE 301 171 2 4
FUROSEMIDE 224 219 3 6
WARFARIN SODIUM 202 184 4 11
METOPROLOL TARTRATE 200 165 5 10
SIMVASTATIN 175 156 6 1
METFORMIN HCL 172 140 7 8
LISINOPRIL 131 117 8 7
FAMOTIDINE 128 102 9 34
AMLODIPINE BESYLATE 126 102 10 2
NAMENDA 124 124 11 32
TAMSULOSIN HCL 112 75 12 29
OXYCONTIN 112 111 S2 12 98
POTASSIUM CHLORIDE 106 94 14 24
METOPROLOL SUCCINATE 98 57 15 9
CLOPIDOGREL 98 98 15 22
POLYETHYLENE GLYCOL 3350 83 56 17 75
PLAVIX 79 79 18 38
HYDROCHLOROTHIAZIDE 79 63 18 12
OXYBUTYNIN CHLORIDE ER 79 67 18 138
DONEPEZIL HCL 79 79 18 20
ESCITALOPRAM OXALATE 78 78 22 46
CYMBALTA 75 74 23 61
AZITHROMYCIN 75 61 23 27
ATORVASTATIN CALCIUM 72 60 25 5
ALENDRONATE SODIUM 69 33 26 30
ENALAPRIL MALEATE 67 56 27 25
PAROXETINE HCL 66 58 28 77
ADVAIR DISKUS 63 33 29 36
CELEBREX 60 60 30 74
DIOVAN 57 35 31 13
MELOXICAM 57 57 31 49
PROPRANOLOL HCL 56 30 33 245
COUMADIN 55 55 34 261
LIDODERM 55 55 34 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.